Table 105Base case results, immunomodulatory agents

TreatmentTotal costsTotal QALYsICER
Macrolide (azithromycin)£158,40414.20-
Oral corticosteroid (prednisolone)£289,61912.53Dominated
NSAID (ibuprofen)£291,03512.26Dominated
“No treatment”£302,04512.37Dominated
Inhaled corticosteroid (fluticasone)£411,04611.11Dominated

ICER, incremental cost-effectiveness ratio; NSAID, nonsteroidal anti-inflammatory drugs; QALYs, qualityadjusted life years

From: Appendix K, Health Economics

Cover of Cystic Fibrosis
Cystic Fibrosis: Diagnosis and management.
NICE Guideline, No. 78.
National Guideline Alliance (UK).
Copyright © NICE 2017.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.